STEMedicine

Innovation Publishing House Pte. Ltd.

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

STEMedicine is an open-access journal published by Innovation Publishing House Pte. Ltd. in Singapore, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,200 USD. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Innovation Publishing House Pte. Ltd.
ISSN
2705-1188
Country
Singapore
Languages
english
Access
Open access
Declared publication charge
1,200 USD
Articles in DOAJ
79
Declared review time
6 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2020-08-10
Indexing
DOAJ
APC
1,200 USD
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2024
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

79

Most recent article

2 years ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

80

Last recorded publication year

2024

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

12

i10-index

16

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2021-11-25
Added to DOAJ
2020-08-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
PKP PNPortico
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification4

Subjects (DOAJ)

Medicine: Medicine (General)Science: Biology (General)

LCC codes

R5-920QH301-705.5

Subject areas

  • MicroRNA in disease regulation
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
  • Mesenchymal stem cell research
  • Cancer-related molecular mechanisms research
  • Neuroscience and Neuropharmacology Research
  • Circular RNAs in diseases
  • Circular RNAs in diseases
Show all subjects (75)
  • Neurogenesis and neuroplasticity mechanisms
  • Cancer Cells and Metastasis
  • MicroRNA in disease regulation
  • Mesenchymal stem cell research
  • Mesenchymal stem cell research
  • Computational Drug Discovery Methods
  • Brain Tumor Detection and Classification
  • Neuroscience and Neural Engineering
  • Flavonoids in Medical Research
  • Tissue Engineering and Regenerative Medicine
  • Alzheimer's disease research and treatments
  • Brain Tumor Detection and Classification
  • Neuroscience and Neuropharmacology Research
  • Ion Channels and Receptors
  • Neuroscience and Neural Engineering
  • Brain Tumor Detection and Classification
  • MicroRNA in disease regulation
  • Neurological Disease Mechanisms and Treatments
  • Photoreceptor and optogenetics research
  • Neurological Disease Mechanisms and Treatments
  • Photoreceptor and optogenetics research
  • Endoplasmic Reticulum Stress and Disease
  • Computational Drug Discovery Methods
  • Advanced Neural Network Applications
  • 3D Printing in Biomedical Research
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Neuroscience and Neuropharmacology Research
  • Endoplasmic Reticulum Stress and Disease
  • Medicinal Plant Research
  • Fatty Acid Research and Health
  • Ubiquitin and proteasome pathways
  • Genomics, phytochemicals, and oxidative stress
  • RNA modifications and cancer
  • Microtubule and mitosis dynamics
  • Cancer-related molecular mechanisms research
  • interferon and immune responses
  • SARS-CoV-2 and COVID-19 Research
  • Pregnancy and preeclampsia studies
  • Gestational Diabetes Research and Management
  • Lung Cancer Treatments and Mutations
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Fatty Acid Research and Health
  • Genomics, phytochemicals, and oxidative stress
  • Ubiquitin and proteasome pathways
  • Pluripotent Stem Cells Research
  • RNA Research and Splicing
  • Cancer-related molecular mechanisms research
  • Microtubule and mitosis dynamics
  • Microtubule and mitosis dynamics
  • RNA modifications and cancer
  • Cellular Mechanics and Interactions
  • interferon and immune responses
  • Pregnancy and preeclampsia studies
  • Gestational Diabetes Research and Management
  • Lung Cancer Treatments and Mutations
  • Pregnancy and preeclampsia studies
  • SARS-CoV-2 and COVID-19 Research
  • Lung Cancer Treatments and Mutations
  • Acute Myocardial Infarction Research
  • Lung Cancer Diagnosis and Treatment
  • Anesthesia and Pain Management
  • Cancer Immunotherapy and Biomarkers
  • SARS-CoV-2 and COVID-19 Research
  • Hearing, Cochlea, Tinnitus, Genetics
  • Neuroinflammation and Neurodegeneration Mechanisms
  • RNA Research and Splicing

Keywords (DOAJ)

  • stem cell
  • molecular medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: